• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Memorial Sloan Kettering Cancer Center, New York, NY

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 8 of 8

  • Page:
  • 1
  • 2

Immersive Connectivism Learning in Neuro-oncology: A Curriculum Innovation Initiative

Author:Thomas, Alissa   Hemminger, Lauryn   Jordan, Justin   Magge, Rajiv   Nevel, Kathryn   Schaff, Lauren   Strowd, Roy   Mohile, Nimish   

Session Name:P7: Education, Research, and Methodology: Neurology Resident Education—Focus on Curriculum 2  

Topic:Education, Research, and Methodology  

Program Number:P7.008  

Author Institution:University of Vermont Medical Center, Burlington, VT  Strong Memorial Hospital, Rochester, NY  Massachusetts General Hospital, Boston, MA  Weill Cornell Brain Tumor Center, New York, NY  Indiana University School of Medicine, Indianapolis, IN  Memorial Sloan Kettering Cancer Center, New York, NY  Wake Forest School Of Medicine, Winston Salem, NC  University of Rochester Medical Center, Rochester, NY  

  • View Abstract
  • View Disclosure

Non-motor Effects of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study

Author:Sarva, Harini   Henchcliffe, Claire   Lozano, Andres   Kalia, Suneil   Yu, Kenny Kwok Hei   Brennan, Cameron   York, Michele   stemple, Whitney   Abid, Nauman   Yountz, Marcus   Enayetallah, Ahmed   Lampron, Antoine   Tabar, Viviane   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.001  

Author Institution:Weill Cornell Medical Center, New York, NY  University of California, Irvine, Orange, CA  Toronto Western Hosp, Toronto, ON, Canada  University of Toronto, Toronto, ON, Canada  Memorial Sloan Kettering Cancer Center, New York, NY  Baylor College of Medicine, Houston, TX  BlueRock Therapeutics, Cambridge, MA  

  • View Abstract
  • View Disclosure

Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study

Author:Henchcliffe, Claire   Sarva, Harini   Lozano, Andres   Fasano, Alfonso   Kalia, Suneil   Yu, Kenny Kwok Hei   Brennan, Cameron   stemple, Whitney   Abid, Nauman   Yountz, Marcus   Enayetallah, Ahmed   Lampron, Antoine   Tabar, Viviane   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.007  

Author Institution:University of California, Irvine, Orange, CA  Weill Cornell Medical Center, New York, NY  Toronto Western Hosp, Toronto, ON, Canada  Toronto Western Hospital - U of Toronto, Toronto, ON, Canada  University of Toronto, Toronto, ON, Canada  Memorial Sloan Kettering Cancer Center, New York, NY  BlueRock Therapeutics, Cambridge, MA  

  • View Abstract
  • View Disclosure

Displaying 6 - 8 of 8

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com